- Home
- BRT vs OSUR Comparison
BRT vs OSUR Comparison
Compare BRT & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRT | OSUR |
|---|---|---|
| Founded | 1972 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.9M | 275.4M |
| IPO Year | 1994 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BRT | OSUR |
|---|---|---|
| Price | $14.93 | $4.23 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $19.75 | $3.00 |
| AVG Volume (30 Days) | 21.5K | ★ 818.8K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 7.03% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $97,028,000.00 | ★ $167,064,000.00 |
| Revenue This Year | $3.82 | $4.48 |
| Revenue Next Year | $5.35 | $7.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1.46 | N/A |
| 52 Week Low | $13.18 | $2.08 |
| 52 Week High | $16.69 | $4.33 |
Technical Indicators
Market Signals| Indicator | BRT | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 62.89 | 65.34 |
| Support Level | $14.23 | $2.80 |
| Resistance Level | $14.93 | $4.33 |
| Average True Range (ATR) | 0.33 | 0.25 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 76.34 | 90.87 |
Price Performance
Historical ComparisonAbout BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.